The Forge presents a two-part, interactive workshop featuring U.S.-based Knobbe Martens and Ontario-based, Epineuron.

This session is a continuation of our first workshop on IP strategy for healthtech/medtech companies (held on February 4, 2021). We will discuss what investors are looking for in respect to IP, the due diligence process, some common pitfalls to avoid, and how to set yourself up for investment success. Like part one, we will have Mike and Sergio from Epineuron present to help illustrate points being made by Ted and Michael from Knobbe Martens.

Participants are welcome to join the second session, without attending the first session of the workshop series. This workshop is scheduled for two hours. The first hour will cover the topics discussed below; the final hour will be for questions. Lawyers from Knobbe Martens and founders from Epineuron will make themselves available for companies interested in speaking with them. We will use breakout rooms for this part of the session.

Topics:

– Due diligence

– The process

– What are investors looking for and how to prepare yourself

– Red flags for investors / avoiding pitfalls

– How to meet medtech investors